<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180623040211N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-05-28</date_registration>
      <primary_sponsor>Bagheiat-allah University of Medical Sciences</primary_sponsor>
      <public_title>The effectiveness of Iranian traditional medicine in  functional bloating</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of lifestyle intervention based on Iranian traditional medicine prespective in patient with functional bloating</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-01-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/39351</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The patients were randomly divided into intervention and control groups using a lottery method. As the names of all participants are placed inside the container. The names are drawn out from the container, respectively, and placed in the intervention and control groups. At the end, the papers containing the names are opened and different groups are determined.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Functional Bloating.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Functional bloating patients are taught the teachings of the style of life based on Iranian medicine.  These fifteen trainings have already been prepared and standardized by a group of traditional medicine specialists and include eating, drinking, sleeping, physical and sexual activity, such as avoiding overeating, avoiding eating several types of foods together, and so on.  Standardized recommendations can be provided if required. Intervention 2: Control group: A number of patients with functional bloating are placed in the control group. These patients are requested to make no changes to their lifestyle, eating and drinking habits during the two months of the clinical trial.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ahmad Reza Sharifi Alun-abadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Baqiyatallah University of Medical Sciences, Shahid Nasrati Alley, South Sheikh Bahayi St, Mulla Sadra St, Vank Square, Tehran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1435916471</zip>
        <telephone>+98 21 8248 2415</telephone>
        <email>a-sharifi@shahed.ac.ir</email>
        <affiliation>Bagheiat-allah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ahmadreza Sharifi Alun-abadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Baqiyatallah University of Medical Sciences, Shahid Nasrati Alley, South Sheikh Bahayi St, Mulla Sadra St, Vank Square, Tehran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1435916471</zip>
        <telephone>+98 21 8248 2415</telephone>
        <email>a-sharifi@shahed.ac.ir</email>
        <affiliation>Bagheiat-allah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with functional bloating symptoms consistent with ROME III criteria include: 1.Recurrent feeling of bloating or visible distension at least 3 days/month in the last 3 months; 2.Insufficient criteria for a diagnosis of functional dyspepsia, irritable bowel syndrome, or other functional GI disorder. Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Existing gastrointestinal ulcer diagnosis by internal medicine specialist;
Acute abdominal pain;
Gastrointestinal organ diseases such as inflammatory bowel disease, peptic ulcer or duodenal ulcer and functional constipation are recognized by an internal medicine specialist;
Severe mental illness;
Severe uncontrolled systemic diseases such as cardiac, pulmonary, and hepatic impairment;
Taking aspirin or nonsteroidal anti-inflammatory drugs, corticosteroids, antibiotics, proton pump inhibitor drugs;
Pregnancy or breastfeeding;
Severe weight loss, black stool or bitumen color;</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R14</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Flatulence and related conditions</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Functional bloating patients are taught the teachings of the style of life based on Iranian medicine.  These fifteen trainings have already been prepared and standardized by a group of traditional medicine specialists and include eating, drinking, sleeping, physical and sexual activity, such as avoiding overeating, avoiding eating several types of foods together, and so on.  Standardized recommendations can be provided if required.</i_keyword>
      <i_keyword>Control group: A number of patients with functional bloating are placed in the control group. These patients are requested to make no changes to their lifestyle, eating and drinking habits during the two months of the clinical trial.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The score of the functional bloating complications questionaire. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Functional bloating complications questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The amount of epigastric distension after the usual meal. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The amount of distension and bulging in the lower abdomen. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The intensity of rectal gas (flatulence). Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The amount of burping (eructation). Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The intensity of abdominal rumbling. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The intensity of early satiety in eating (The inability to finish the usual meal). Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The severity of postprandial fullness after a typical meal. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The intensity of bloating after bloatable food eating. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The intensity of bloating in hunger and without food. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The intensity of bloating during menstruation. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The intensity of nausea after eating. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The intensity of nausea  in hunger and without food. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The intensity of retching. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
      <sec_outcome>The intensity of epigastric pain. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Bagheiat-allah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-03-13</approval_date>
        <contact_name>The Ethics Committee of Baqiyatallah University of Medical Sciences</contact_name>
        <contact_address>Baqiyatallah University of Medical Sciences, Shahid Nasrati Alley, South Sheikh Bahayi St, Mulla Sadra St, Vank Square, Tehran. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
